TrialCancer immunology, immunotherapy : CII2019

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.

Sandra P D'Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.